$178.00 - $4,651.50

$178.00 - $4.00

Choose an Option...
  • 100 mg - $4,651.50
  • 50 mg - $3,286.00
  • 25 mg - $2,183.00
  • 5 mg - $652.00
  • 1 mg - $178.00
  • Custom Amount (Quotes Only)
In stock
Only %1 left

Product Description

The APA5 monoclonal antibody reacts with mouse PDGFRα (platelet-derived growth factor alpha), a subtype of the type III receptor tyrosine kinase PDGFR. This antibody does not bind PDGFRβ, c-Fms, Flk1, Flk2, or the IL-7 receptor. PDGFRα is involved in the embryonic regulation of organogenesis, including alveogenesis, hair morphogenesis, spermatogenesis, oligodendrogenesis, palate genesis, angiogenesis, and glomerulogenesis, and it regulates the processes of cellular proliferation, survival, and chemotaxis during wound healing. In mature organisms, PDGFRα is expressed in several interstitial-type cells, such as the fibroblasts of the heart, lungs, and dermis, as well as in hepatic stellate cells and renal mesangial cells. PDGFRα is considered a general marker for fibroblasts and mesenchymal cells and a useful identifier of progenitor cell populations across multiple mesodermal tissues. PDGFRα is involved in platelet activation, the secretion of agonists from platelet granules, and thrombin-induced platelet aggregation. At the molecular level, PDGFRα acts as a cell-surface receptor for its cognate ligands, PDGF-AA, PDGF-BB, and PDGF-CC, whereas PDGFRβ binds PDGF-DD. PDGFRα dimerizes in response to ligand binding, forming PDGFRα-PDGFRα homodimers and PDGFRα-PDGFRβ heterodimers. In vivo mouse knockout phenotype data have suggested that the binding of PDGFRα to its ligands PDGF-AA and PDGF-CC solely activates PDGFRα signaling during development, while PDGFRα binding with PDGF-BB activates PDGFRβ signaling. PDGFRα phosphorylates PIK3R1, PLCG1, and PTPN11, and it is involved in AKT, MAPK, and STAT signaling pathways.

Specifications

Isotype Rat IgG2a, κ
Recommended Isotype Control(s) InVivoMAb rat IgG2a isotype control, anti-trinitrophenol
Recommended Dilution Buffer InVivoPure pH 7.0 Dilution Buffer
Immunogen Recombinant mPDGFRα-human IgG1 fusion protein
Reported Applications in vivo blocking of PDGFRα
in vitro blocking of PDGFRα
Functional assays
Immunohistochemistry (paraffin)
Immunohistochemistry (whole-mount)
Flow cytometry
Western blot
ELISA
Formulation PBS, pH 7.0
Contains no stabilizers or preservatives
Endotoxin ≤1EU/mg (≤0.001EU/μg)
Determined by LAL assay
Purity ≥95%
Determined by SDS-PAGE
Sterility 0.2 µm filtration
Production Purified from cell culture supernatant in an animal-free facility
Purification Protein G
Molecular Weight 150 kDa
Storage The antibody solution should be stored at the stock concentration at 4°C. Do not freeze.
Need a Custom Formulation? See All Antibody Customization Options

Application References

  • in vivo blocking of PDGFRα in vitro blocking of PDGFRα Western Blot Immunohistochemistry (paraffin) ELISA
    Takakura N, Yoshida H, Kunisada T, Nishikawa S, Nishikawa SI (1996). "Involvement of platelet-derived growth factor receptor-alpha in hair canal formation" J Invest Dermatol 107(5):770-7.

    Hair follicles develop and are maintained by multiple rounds of inductive events involving interactions among various cell types within the follicles and the adjacent mesenchyme. Although evidence suggests that several growth factors, cell adhesion molecules, and transcriptional regulators are involved in those cell-cell interactions, the molecular mechanisms regulating each pivotal step of hair follicle development, such as formation of the hair germ, root sheath, sebaceous gland, and hair canal, remain largely unknown. In this study, we established the antagonistic monoclonal antibody APA5 against platelet-derived growth factor (PDGF) receptor-alpha (PDGFR-alpha) and used it to investigate the role of PDGFR-alpha in neonatal skin development. In addition to the dermal mesenchyme, a known site of PDGFR-alpha expression, immunohistologic staining of neonatal skin detected transient expression of PDGFR-alpha in the perinatal epidermis for several days. On the other hand, ligands for PDGFR-alpha were detected in epithelial cells and sebaceous glands of hair follicles. To determine whether this contiguous expression of PDGF and PDGFR-alpha in neonatal skin plays a functional role, we injected APA5 into neonates to block the function of PDGFR-alpha. Consistent with the PDGF/PDGFR-alpha expression in the neonatal skin, two defects were induced by this procedure. First, hair canal formation in the epidermis was severely suppressed. Second, the growth of dermal connective tissues and of hair follicles of pelage hairs was suppressed. These results indicate that PDGF signals are involved in both the epidermis-follicle interaction and the dermal mesenchyme-follicle interaction required for hair canal formation and the growth of the dermal mesenchyme, respectively.

  • in vivo blocking of PDGFRα
    Yoshida H, Takakura N, Kataoka H, Kunisada T, Okamura H, Nishikawa SI (1997). "Stepwise requirement of c-kit tyrosine kinase in mouse ovarian follicle development" Dev Biol 184(1):122-37.

    Ovarian follicle development is controlled by the cycling variation of gonadotrophins derived from the central nervous system. Intragonadal signals are also required, especially in the autonomous development of small follicles. Receptor tyrosine kinase c-kit and its ligand SLF (Steel factor) are expressed on the surface of specific populations of follicle-forming cells in a contiguous manner and are thought to have important roles in follicular development. We blocked the interaction of c-kit and its ligand by administering the function-blocking antibody ACK2 to developing mice at various times after birth and monitored ovarian follicle development. A blockade of c-kit function disturbed the onset of primordial follicle development, primary follicle growth, follicular fluid formation of preantral follicles, and penultimate-stage ovarian follicle maturation before ovulation. Ovarian follicle growth was dependent on c-kit during the first 5 days after birth when the functional FSH receptor is not yet expressed in mouse ovary. In contrast, primordial follicle formation and survival, small preantral or antral follicle development, ovulation, and luteinization of the ovulated follicle were not affected by this antibody. These findings indicate the stepwise requirement of c-kit and its ligand interaction system in the developing ovarian follicle and that c-kit with its ligand supports the autonomous development of ovarian follicle independent of gonadotrophins.

  • in vivo blocking of PDGFRα
    Liao CH, Akazawa H, Tamagawa M, Ito K, Yasuda N, Kudo Y, Yamamoto R, Ozasa Y, Fujimoto M, Wang P, Nakauchi H, Nakaya H, Komuro I (2010). "Cardiac mast cells cause atrial fibrillation through PDGF-A-mediated fibrosis in pressure-overloaded mouse heart

    Atrial fibrillation (AF) is a common arrhythmia that increases the risk of stroke and heart failure. Here, we have shown that mast cells, key mediators of allergic and immune responses, are critically involved in AF pathogenesis in stressed mouse hearts. Pressure overload induced mast cell infiltration and fibrosis in the atrium and enhanced AF susceptibility following atrial burst stimulation. Both atrial fibrosis and AF inducibility were attenuated by stabilization of mast cells with cromolyn and by BM reconstitution from mast cell-deficient WBB6F1-KitW/W-v mice. When cocultured with cardiac myocytes or fibroblasts, BM-derived mouse mast cells increased platelet-derived growth factor A (PDGF-A) synthesis and promoted cell proliferation and collagen expression in cardiac fibroblasts. These changes were abolished by treatment with a neutralizing antibody specific for PDGF alpha-receptor (PDGFR-alpha). Consistent with these data, upregulation of atrial Pdgfa expression in pressure-overloaded hearts was suppressed by BM reconstitution from WBB6F1-KitW/W-v mice. Furthermore, injection of the neutralizing PDGFR-alpha-specific antibody attenuated atrial fibrosis and AF inducibility in pressure-overloaded hearts, whereas administration of homodimer of PDGF-A (PDGF-AA) promoted atrial fibrosis and enhanced AF susceptibility in normal hearts. Our results suggest a crucial role for mast cells in AF and highlight a potential application of controlling the mast cell/PDGF-A axis to achieve upstream prevention of AF in stressed hearts.

  • in vivo blocking of PDGFRα Immunohistochemistry (whole-mount)
    Fruttiger M, Calver AR, Krüger WH, Mudhar HS, Michalovich D, Takakura N, Nishikawa S, Richardson WD (1996). "PDGF mediates a neuron-astrocyte interaction in the developing retina" Neuron 17(6):1117-31.

    Astrocytes invade the developing retina from the optic nerve head, over the axons of retinal ganglion cells (RGCs). RGCs express the platelet-derived growth factor A-chain (PDGF-A) and retinal astrocytes the PDGF alpha-receptor (PDGFR alpha), suggesting that PDGF mediates a paracrine interaction between these cells. To test this, we inhibited PDGF signaling in the eye with a neutralizing anti-PDGFR alpha antibody or a soluble extracellular fragment of PDGFR alpha. These treatments inhibited development of the astrocyte network. We also generated transgenic mice that overexpress PDGF-A in RGCs. This resulted in hyperproliferation of astrocytes, which in turn induced excessive vasculogenesis. Thus, PDGF appears to be a link in the chain of cell-cell interactions responsible for matching numbers of neurons, astrocytes, and blood vessels during retinal development.

Product FAQs